A Study of Itacitinib for the Treatment of Chronic Graft Versus Host Disease (cGVHD)
Status:
Recruiting
Trial end date:
2024-06-01
Target enrollment:
Participant gender:
Summary
This study is being done in patients who have been receiving corticosteroids or other
immunosuppressive therapies for the treatment of cGVHD for at least 6 months. The purpose of
this study is to find out if itacitinib in combination with corticosteroids or other
immunosuppressive therapies is safe and effective in people with cGVHD.